The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.

por Steger, G. G., Kaboo, R., deKernion, J. B., Figlin, R., Belldegrun, A.
Publicado 1995

Genetic analysis of multiple synchronous lesions of the colon adenoma–carcinoma sequence

por Sedivy, R, Wolf, B, Kalipciyan, M, Steger, G G, Karner-Hanusch, J, Mader, R M
Publicado 2000

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

por Zielinski, C. C., Schnack, B., Grbovic, M., Brodowicz, T., Wiltschke, C., Steger, G., Pflüger, H., Marberger, M.
Publicado 1998

Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer

por Mader, R M, Schrolnberger, C, Rizovski, B, Brunner, M, Wenzel, C, Locker, G, Eichler, H G, Mueller, M, Steger, G G
Publicado 2003

Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival

por Wimmer, K., Bolliger, M., Bago-Horvath, Z., Steger, G., Kauer-Dorner, D., Helfgott, R., Gruber, C., Moinfar, F., Mittlböck, M., Fitzal, F.
Publicado 2019

Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatm...

por Hudelist, G, Köstler, W J, Attems, J, Czerwenka, K, Müller, R, Manavi, M, Steger, G G, Kubista, E, Zielinski, C C, Singer, C F
Publicado 2003

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

por Zagouri, F, Sergentanis, T N, Koutoulidis, V, Sparber, C, Steger, G G, Dubsky, P, Zografos, G C, Psaltopoulou, T, Gnant, M, Dimopoulos, M-A, Bartsch, R
Publicado 2013

Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Tri...

por Bjelic-Radisic, V., Fitzal, F., Knauer, M., Steger, G., Egle, D., Greil, R., Schrenk, P., Balic, M., Singer, Ch., Exner, R., Soelkner, L., Gnant, Michael
Publicado 2020

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

por Schippinger, W, Jagoditsch, M, Sorré, C, Gnant, M, Steger, G, Hausmaninger, H, Mlineritsch, B, Schaberl-Moser, R, Mischinger, H J, Hofbauer, F, Holzberger, P, Mittlböck, M, Jakesz, R
Publicado 2005

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

por Berghoff, A S, Bago-Horvath, Z, Ilhan-Mutlu, A, Magerle, M, Dieckmann, K, Marosi, C, Birner, P, Widhalm, G, Steger, G G, Zielinski, C C, Bartsch, R, Preusser, M
Publicado 2012

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the...

por Gnant, M, Pfeiler, G, Stöger, H, Mlineritsch, B, Fitzal, F, Balic, M, Kwasny, W, Seifert, M, Stierer, M, Dubsky, P, Greil, R, Steger, G, Samonigg, H, Fesl, C, Jakesz, R
Publicado 2013

Prognostic impact of breast cancer subtypes in elderly patients

por Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Publicado 2016

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

por Michlmayr, A, Bachleitner-Hofmann, T, Baumann, S, Marchetti-Deschmann, M, Rech-Weichselbraun, I, Burghuber, C, Pluschnig, U, Bartsch, R, Graf, A, Greil, R, Allmaier, G, Steger, G, Gnant, M, Bergmann, M, Oehler, R
Publicado 2010

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

por Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, Jagoditsch, M, Steger, G G, Jakesz, R, Herbst, F, Hofbauer, F, Rabl, H, Wohlmuth, P, Gnant, M, Thaler, J
Publicado 2007

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

por Bartsch, R, Berghoff, A, Pluschnig, U, Bago-Horvath, Z, Dubsky, P, Rottenfusser, A, DeVries, C, Rudas, M, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G
Publicado 2012

Brain metastases free survival differs between breast cancer subtypes

por Berghoff, A, Bago-Horvath, Z, De Vries, C, Dubsky, P, Pluschnig, U, Rudas, M, Rottenfusser, A, Knauer, M, Eiter, H, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G, Preusser, M, Bartsch, R
Publicado 2012

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the AB...

por Pfeiler, G, Stöger, H, Dubsky, P, Mlineritsch, B, Singer, C, Balic, M, Fitzal, F, Moik, M, Kwasny, W, Selim, U, Renner, K, Ploner, F, Steger, G G, Seifert, M, Hofbauer, F, Sandbichler, P, Samonigg, H, Jakesz, R, Greil, R, Fesl, C, Gnant, M
Publicado 2013